Capital Flow Monitor · Sponsors · CIK 1797915

Hexamer Therapeutics, Inc

2345 NE HOPKINS CT, PULLMAN, WA, 99163 · 509-715-9251

Biotechnology · Corporation· inc. DELAWARE true

Fit score

—

Offering

$2.5M

Sold

$500K

% sold

20.0%

Investors

2

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-09-15 D ·current 506(b) $2.5M $500K 20.0% 2 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

  • Robert H Bogden — Executive Officer / Director, Pullman, WA
  • Colin Collins — Director, Vancouver, A1
  • Keith Miller — Director, Moscow, ID
    1 other raise
  • R. Scott Blackley — Director, Leesburg, VT
  • Stephen Crawford — Director, Bronxville, NY
  • Brad Call — Director, Pullman, WA

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.